As expected under the diametric model of autism and psychosis in psychopharmacology, some treatments with mGlur5 antagonists in autistic conditions result not just in tendencies toward normalization, but also in symptoms of psychosis (e.g. [179]) that are indicative of ‘over-effectiveness’. The gene discussed is GRM5; the disease is psychotic disorder.